BioLight Life Revenue vs. Current Asset

BOLT Stock  ILS 436.50  13.50  3.00%   
Based on the measurements of profitability obtained from BioLight Life's financial statements, BioLight Life Sciences may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in April. Profitability indicators assess BioLight Life's ability to earn profits and add value for shareholders.
For BioLight Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioLight Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioLight Life Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioLight Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioLight Life Sciences over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between BioLight Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLight Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLight Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

BioLight Life Sciences Current Asset vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining BioLight Life's current stock value. Our valuation model uses many indicators to compare BioLight Life value to that of its competitors to determine the firm's financial worth.
BioLight Life Sciences is the top company in revenue category among related companies. It is number one stock in current asset category among related companies fabricating about  15,000  of Current Asset per Revenue. . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioLight Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioLight Life's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioLight Life's earnings, one of the primary drivers of an investment's value.

BioLight Revenue vs. Competition

BioLight Life Sciences is the top company in revenue category among related companies. Market size based on revenue of Health Care industry is currently estimated at about 34.46 Billion. BioLight Life adds roughly 3,000 in revenue claiming only tiny portion of equities under Health Care industry.

BioLight Current Asset vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

BioLight Life

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

BioLight Life

Current Asset

 = 

Cash

+

Deposits

+

Liquid Assets

 = 
45 M
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets since these assets can be easily liquidated in case the company goes bankrupt. However, it is usually not enough to know if a company is in good shape just based on current asset alone; the amount of current liabilities should always be considered.

BioLight Current Asset Comparison

BioLight Life is currently under evaluation in current asset category among related companies.

BioLight Life Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in BioLight Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioLight Life will eventually generate negative long term returns. The profitability progress is the general direction of BioLight Life's change in net profit over the period of time. It can combine multiple indicators of BioLight Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioLight Life Sciences Ltd., an ophthalmic company, engages in the discovery, development, and commercialization of products and product candidates that address ophthalmic conditions comprising glaucoma, dry eye syndrome, and age-related macular degeneration. BioLight Life Sciences Ltd. was founded in 2005 and is based in Tel Aviv, Israel. BIOLIGHT LIFE operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange.

BioLight Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on BioLight Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioLight Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioLight Life's important profitability drivers and their relationship over time.

Use BioLight Life in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLight Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLight Life will appreciate offsetting losses from the drop in the long position's value.

BioLight Life Pair Trading

BioLight Life Sciences Pair Trading Analysis

The ability to find closely correlated positions to BioLight Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLight Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLight Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLight Life Sciences to buy it.
The correlation of BioLight Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLight Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLight Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLight Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your BioLight Life position

In addition to having BioLight Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Market Neutral Funds Thematic Idea Now

Market Neutral Funds
Market Neutral Funds Theme
Funds or Etfs that invest in both long and short positions of different entities to enhance returns from broad market movements over time. The Market Neutral Funds theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Market Neutral Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities.
You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for BioLight Stock analysis

When running BioLight Life's price analysis, check to measure BioLight Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLight Life is operating at the current time. Most of BioLight Life's value examination focuses on studying past and present price action to predict the probability of BioLight Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLight Life's price. Additionally, you may evaluate how the addition of BioLight Life to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Stocks Directory
Find actively traded stocks across global markets
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
To fully project BioLight Life's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioLight Life Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioLight Life's income statement, its balance sheet, and the statement of cash flows.
Potential BioLight Life investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although BioLight Life investors may work on each financial statement separately, they are all related. The changes in BioLight Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on BioLight Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.